港股公司信息更新报告：2023Q2FILA流水如期回暖，其他品牌持续发力 微创脑科学2023H1业绩快报点评：收入加速增长，全年高增长可期 净利息收入强和非息收入弱趋势延续 思摩尔国际点评报告：23Q2海外稳健增长，一次性产品持续放量 每日晨报 23Q2业绩前瞻：618提振零售，言犀大模型发布 每日港股导航 每日晨讯 股权激励落地，吸引人才促进发展 A high-quality 2Q23 and guidance unchanged

Reaffirming top pick for 30% earnings CAGR amid margin expansion Promoting credit cards to offset deleveraging pressure 1H17 first read is positive. Margin expanded, earnings in-line 1H17 in line–firing on all cylinders 1H17 weakness as guided; recovery path still full of challenges NDR takeaways Earnings beat, first interim dividend Both businesses in early growth cycle Decent results delivered Buy: Interim result indicates better-than-expected 2017